Japan MitraClip NT Postmarketing Surveillance
Showing 1 - 25 of 4,047
MitraClip NT System Post-marketing Surveillance Study - Japan
Completed
- Mitral Regurgitation
- Mitral Valve Regurgitation
- MitraClip NT System
-
Nagoya, Aichi, Japan
- +39 more
Jul 12, 2022
Yervoy® Postmarketing Surveillance for Japan With Unresectable,
Completed
- Melanoma
-
Chiyoda-ku, Tokyo, Japan
- +1 more
Feb 11, 2022
A Survey of Darvadstrocel in People With Crohn's Disease
Recruiting
- Crohn's Disease
- Darvadstrocel
-
Tokyo, JapanTakeda selected site
Dec 5, 2022
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
Apr 21, 2023
Mitral Regurgitation Trial in France, Monaco (percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP
Recruiting
- Mitral Regurgitation
- percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW
- cardiac surgery
-
Angers, France
- +32 more
Jan 23, 2023
Proportion of Hepatic Toxicity and All Adverse Drug Reactions in
Completed
- Hepatitis C
-
Tokyo, JapanLocal Institution
Feb 7, 2022
Empliciti in Korean Patients With Multiple Myeloma
Withdrawn
- Multiple Myeloma
- Non-Interventional
-
Seoul, Korea, Republic ofLocal Institution
May 24, 2022
Korea Osimertinib Real World Evidence Study to Assess Safety and
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Busan, Korea, Republic of
- +10 more
Aug 18, 2022
Quadrivalent Influenza Vaccine in Subjects Aged 6 to 35 Months
Completed
- Influenza
- VaxigripTetra®
-
Gangwon-do, Korea, Republic of
- +11 more
Apr 26, 2023
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Completed
- Thoracic Aortic Aneurysm
- +2 more
- Conformable GORE® TAG® Thoracic Endoprosthesis
- (no location specified)
Jan 11, 2023
Mitral Regurgitation, Mitral Valve Regurgitation, Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure
Active, not recruiting
- Mitral Regurgitation
- +3 more
- MitraClip System
-
Birmingham, Alabama
- +85 more
Sep 21, 2022
Phenotypic Classification of FMR With CMR
Not yet recruiting
- Nonischemic Congestive Cardiomyopathy
- Functional Mitral Regurgitation
- Cardiac magnetic resonance (CMR)
-
Cleveland, OhioCleveland Clinic
Jul 28, 2023
Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing
Not yet recruiting
- Unresectable Hepatocellular Carcinoma
- (no location specified)
Dec 19, 2022
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance
Not yet recruiting
- Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
- (no location specified)
Dec 16, 2022
Aortic Stenosis, Calcific, Aortic Valve Stenosis Trial in Worldwide (SAPIEN 3 / SAPIEN 3 Ultra)
Recruiting
- Aortic Stenosis, Calcific
- Aortic Valve Stenosis
- SAPIEN 3 / SAPIEN 3 Ultra
-
Los Angeles, California
- +38 more
Aug 1, 2022
Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)
Recruiting
- SARS-CoV-2 Infection
-
Aichi, Japan
- +2 more
Jan 17, 2023
Assess Deucravacitinib Post-marketing Surveillance in Psoriasis
Not yet recruiting
- Psoriasis
-
Tosima-ku, Tokyo, JapanLocal Institution
Nov 22, 2022
Mitral Valve Insufficiency Trial in Edegem, Aalst (mitraclip)
Recruiting
- Mitral Valve Insufficiency
- mitraclip
-
Edegem, Antwerp, Belgium
- +1 more
Nov 6, 2022
Biomarkers in Patients With Suspected HFpEF
Not yet recruiting
- Heart Failure
- +2 more
- Plasma biomarker levels
-
Glasgow, United Kingdom
- +2 more
Oct 20, 2023
The MitraClip® EXPAND Study of Next Generation of MitraClip®
Completed
- Mitral Valve Regurgitation
- Mitral Regurgitation
- MitraClip NTR/XTR System
-
Birmingham, Alabama
- +56 more
Dec 7, 2021
Mitral Valve Regurgitation Trial
Not yet recruiting
- Mitral Valve Regurgitation
- (no location specified)
Jul 15, 2022
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing
Recruiting
- Lupus Erythematosus, Systemic
-
Aichi, Japan
- +93 more
Jan 24, 2023
(Special Use-results Surveillance on Long-term Use) With
Enrolling by invitation
- Adult Growth Hormone Deficiency
-
Fukuoka, Japan
- +6 more
Nov 8, 2022
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -
Not yet recruiting
- Biliary Tract Cancer
- (no location specified)
Apr 26, 2023
Macular Degeneration (AMD) Post-marketing Surveillance in Japan
Completed
- Macular Degeneration
- Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Japan(unnamed)
Jan 9, 2023